Error: Could not add to watchlist. X
+ Watchlist

Vernalis PLC

VER:LN
London
17.63
GBp
0.13
0.71%
As of 11:35 AM EDT 6/28/2017
Open
17.25
Day Range
16.50 - 17.63
Volume
54,179
Previous Close
17.50
52Wk Range
16.00 - 49.50
1 Yr Return
-46.18%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
17.25
Day Range
16.50 - 17.63
Volume
54,179
Previous Close
17.50
52Wk Range
16.00 - 49.50
1 Yr Return
-46.18%
YTD Return
-48.16%
Current P/E Ratio (TTM)
-
Earnings per Share (GBP) (TTM)
-0.04
Market Cap (m GBp)
92.785
Shares Outstanding (m)
526.437
Price/Sales (TTM)
7.58
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.53%
% Price Change
+0.52%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Vernalis plc is a revenue generating development stage pharmaceutical company which has a broad pipeline of research and development programs. The Company is focused on developing products for the US prescription cough and cold market. The Company derives pipeline candidates both from collaborations with global pharmaceutical businesses and their own research activities.
Address
Oakdene Court
613 Reading Road
Winnersh, RG41 5UA
United Kingdom
Phone
44-118-977-3133
  • Ian Garland
    Chief Executive Officer
  • David Mackney
    Chief Financial Officer
  • Sandford Sommer "Sandy"
    Pres & COO:Vernalis Therapeutics
  • Kevin Kissane
    Secretary/General Counsel
Show More